Literature DB >> 23975623

Successful percutaneous endobiliary radiofrequency ablation for unresectable malignant biliary obstruction: a case report and review of the literature.

Eric J Mao1, James B Watson, Gregory Soares, Fadlallah G Habr.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 23975623     DOI： 10.1007/s12029-013-9538-y

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  15 in total

1.  Evaluation of effects of a novel endoscopically applied radiofrequency ablation biliary catheter using an ex-vivo pig liver.

Authors:  Takao Itoi; Hiroyuki Isayama; Atsushi Sofuni; Fumihide Itokawa; Miho Tamura; Yusuke Watanabe; Fuminori Moriyasu; Michel Kahaleh; Nagy Habib; Toshitaka Nagao; Tomohisa Yokoyama; Kazuhiko Kasuya; Hiroshi Kawakami
Journal:  J Hepatobiliary Pancreat Sci       Date:  2012-09       Impact factor: 7.027

Review 2.  Prophylactic gastrojejunostomy for unresectable periampullary carcinoma.

Authors:  Kurinchi Selvan Gurusamy; Senthil Kumar; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

3.  Endobiliary radiofrequency ablation for reopening of occluded biliary stents: a promising technique.

Authors:  Amar Mukund; Ankur Arora; S Rajesh; Prasahant Bothra; Yashwant Patidar
Journal:  J Vasc Interv Radiol       Date:  2013-01       Impact factor: 3.464

4.  Percutaneous intraductal radiofrequency ablation is a safe treatment for malignant biliary obstruction: feasibility and early results.

Authors:  Malkhaz Mizandari; Madhava Pai; Feng Xi; Vlastimil Valek; Andrasina Tomas; Pietro Quaretti; Rita Golfieri; Cristina Mosconi; Ao Guokun; Charis Kyriakides; Robert Dickinson; Joanna Nicholls; Nagy Habib
Journal:  Cardiovasc Intervent Radiol       Date:  2012-12-12       Impact factor: 2.740

5.  15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas.

Authors:  Edwin O Onkendi; Sarah Y Boostrom; Michael G Sarr; Michael B Farnell; David M Nagorney; John H Donohue; Michael L Kendrick; Kaye M Reid-Lombardo; William S Harmsen; Florencia G Que
Journal:  J Gastrointest Surg       Date:  2012-02-17       Impact factor: 3.452

Review 6.  Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update.

Authors:  Stefaan Mulier; Theo Ruers; Jacques Jamart; Luc Michel; Guy Marchal; Yicheng Ni
Journal:  Dig Surg       Date:  2009-02-12       Impact factor: 2.588

7.  Cancer statistics, 2013.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2013-01-17       Impact factor: 508.702

8.  Periampullary adenocarcinoma: analysis of 5-year survivors.

Authors:  C J Yeo; T A Sohn; J L Cameron; R H Hruban; K D Lillemoe; H A Pitt
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

Review 9.  Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies.

Authors:  Yun Ku Cho; Jae Kyun Kim; Mi Young Kim; Hyunchul Rhim; Joon Koo Han
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

10.  Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: a novel palliation technique.

Authors:  Paola Figueroa-Barojas; Mihir R Bakhru; Nagy A Habib; Kristi Ellen; Jennifer Millman; Armeen Jamal-Kabani; Monica Gaidhane; Michel Kahaleh
Journal:  J Oncol       Date:  2013-04-08       Impact factor: 4.375
View more
  4 in total

1.  Optimization of the generator settings for endobiliary radiofrequency ablation.

Authors:  Maximilien Barret; Sarah Leblanc; Ariane Vienne; Alexandre Rouquette; Frederic Beuvon; Stanislas Chaussade; Frederic Prat
Journal:  World J Gastrointest Endosc       Date:  2015-11-10

Review 2.  Intraductal radiofrequency ablation for management of malignant biliary obstruction.

Authors:  Tarun Rustagi; Priya A Jamidar
Journal:  Dig Dis Sci       Date:  2014-06-07       Impact factor: 3.199

3.  Percutaneous Intraductal Radiofrequency Ablation Combined with Biliary Stent Placement for Nonresectable Malignant Biliary Obstruction Improves Stent Patency but not Survival.

Authors:  Jianfeng Wang; Lizhen Zhao; Chuanguo Zhou; Kun Gao; Qiang Huang; Baojie Wei; Jun Gao
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

4.  Intraductal Radiofrequency Ablation Followed by Locoregional Tumor Treatments for Treating Occluded Biliary Stents in Non-Resectable Malignant Biliary Obstruction: A Single-Institution Experience.

Authors:  Xu-Hua Duan; Yan-Li Wang; Xin-Wei Han; Jian-Zhuang Ren; Teng-Fei Li; Jian-Hao Zhang; Kai Zhang; Peng-Fei Chen
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.